Short-term impact of HbA 1c on morbidity and all-cause mortality in people with type 2 diabetes: A Danish population-based observational study

Diabetologia

Volumn 55, Issue 9, 2012, Pages 2361-2370

  Skriver, M V ^a   Stovring H ^a   Kristensen, J K ^a   Charles, M ^a   Sandbaek A ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

All cause mortality; Morbidity; Type 2 diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ARTERIOSCLEROSIS; ARTICLE; DENMARK; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; STROKE;

EID: 84866063358     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2614-1     Document Type: Article

References (25)

1. Sabanayagam C, Liew G, Tai ES et al (2009) Relationship between glycated haemoglobin and microvascular complications: is there a natural cut-off point for the diagnosis of diabetes? Diabetologia 52:1279-1289
2. Van Leiden HA, Dekker JM, Moll AC et al (2003) Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. Arch Ophthalmol 121:245-251
3. Tapp RJ, Tikellis G, Wong TY, Harper CA, Zimmet PZ, Shaw JE (2008) Longitudinal association of glucose metabolism with retinopathy: results from the Australian Diabetes Obesity and Lifestyle (AusDiab) study. Diabetes Care 31:1349-1354
4. Stratton IM, Adler AI, Neil HA et al (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405-412
5. Selvin E, Marinopoulos S, Berkenblit G et al (2004) Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 141:421-431
6. Ray KK, Seshasai SR, Wijesuriya S et al (2009) Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet 373:1765-1772
7. Turnbull FM, Abraira C, Anderson RJ et al (2009) Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia 52:2288-2298
8. Florkowski CM, Scott RS, Moir CL, Graham PJ (1998) Lipid but not glycaemic parameters predict total mortality from type 2 diabetes mellitus in Canterbury, New Zealand. Diabet Med 15:386-392
9. Gall MA, Borch-Johnsen K, Hougaard P, Nielsen FS, Parving HH (1995) Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes 44:1303-1309
10. Currie CJ, Peters JR, Tynan A et al (2010) Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet 375:481-489
11. Nathan DM, Buse JB, Davidson MB et al (2008) Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones. Diabetologia 51:8-11
12. National Board of Health, Danish Centre for Evaluation and Health Technology Assessment Type 2 Diabetes (2005). Health technology assessment of screening, diagnosis and treatment. Danish Health Technology Assessment, Copenhagen 7(1)
13. Kristensen JK, Sandbaek A, Lassen JF, Bro F, Lauritzen T (2001) Use and validation of public data files for identification of the diabetic population in a Danish county. Dan Med Bull 48:33-37
14. Kristensen JK, Drivsholm TB, Carstensen B, Steding-Jensen M, Green A (2007) Validation of methods to identify known diabetes on the basis of health registers. Ugeskr Laeger 169:1687-1692 [article in Danish]
15. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373-383
16. Gallagher EJ, Le RD, Bloomgarden Z (2009) Review of hemoglobin A(1c) in the management of diabetes. J Diabetes 1:9-17
17. Grambsch PM, Therneau TM (1994) Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81:515-526
18. Anonymous (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) UK Prospective Diabetes Study (UKPDS) Group. Lancet 352:837-853
19. Anonymous (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) UK Prospective Diabetes Study (UKPDS) Group. Lancet 352:854-865
20. Lehto S, Ronnemaa T, Pyorala K, Laakso M (1996) Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes. Stroke 27:63-68
21. Moss SE, Klein R, Klein BE, Meuer SM (1994) The association of glycemia and cause-specific mortality in a diabetic population. Arch Intern Med 154:2473-2479
22. Selvin E, Steffes MW, Zhu H et al (2010) Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 362:800-811
23. Carson AP, Fox CS, McGuire DK et al (2010) Low hemoglobin A1c and risk of all-cause mortality among US adults without diabetes. Circ Cardiovasc Qual Outcomes 3:661-667
24. Pfister R, Sharp SJ, Luben R, Khaw KT, Wareham NJ (2011) No evidence of an increased mortality risk associated with low levels of glycated haemoglobin in a non-diabetic UK population. Diabetologia 54:2025-2032
25. International Expert Committee (2009) International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32:1327-1334